Itskovitz-Eldor et al. [25] first described in 2000 that, as for the females with a high risk of OHSS, the adoption of GnRH antagonist protocol with using a single bolus of GnRH-a achieved a 50% pregnancy rate without any symptoms of OHSS. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.